期刊文献+

儿童变态反应性疾病对风湿病的影响

The influence of allergic diseases on children's rheumatic diseases.
原文传递
导出
摘要 变态反应性疾病和风湿性疾病是儿童时期常见的免疫系统紊乱性疾病,其特点为发病率逐年上升,病程长,易反复,不利于患儿病情恢复,明显影响疾病的预后。既往经典的Th1/Th2理论认为:Th1介导的风湿性疾病和Th2介导的变态反应性疾病在免疫机制及发病情况上相互补充,从而出现体内原本失衡的T细胞亚群达到新的平衡,改善了患儿的预后。而近年的研究发现对该理论提出了新的挑战,认为变态反应性疾病和风湿性疾病无论在发病机制还是在临床表现方面均互为危险因素。因此,阐明两者的关系有利于指导临床的诊疗和预后判断。本文拟结合国内外研究进展,把儿童变态反应性疾病对风湿性疾病的影响进展做一阐述。 Allergic disorders and rheumatic diseases are twocommon diseases of dysregulated immune system in children,with the feature of long disease course and easy relapse,andthe incidence of the two diseases is increasing. All these features are bad for the prognosis of children with the diseases.Prior Th1/Th2 theory deemed that Th1-mediated autoimmunediseases and Th2-mediated allergic conditions are complementary both on the mechanism and incidence,which improve patients' outcomes with a new balance of T cell subsets. Recentstudies,however,have served to challenge the idea that thepresence of allergy and autoimmunity are mutually exclusivestates and suggest that allergic diseases and rheumatic diseases are risk factors for each other. Clear understanding of the re-lationship between children's rheumatic diseases and allergicdisorders will have important implications for clinical treatment and diagnosis. This article clarifies the influence of allergic diseases on children's rheumatic disease.
出处 《中国实用儿科杂志》 CSCD 北大核心 2015年第1期17-20,共4页 Chinese Journal of Practical Pediatrics
基金 上海市中医药事业发展三年行动计划第二批重大研究项目(ZYSNXD-CC-ZDYJ030)
关键词 变态反应性疾病 儿童 风湿性疾病 预后 发病机制 allergic disease children rheumatic disease prognosis pathogenesis
  • 相关文献

参考文献32

  • 1Maas T, Nieuwhof C, Passos VL, et al. Transgenerational occur- rence of allergic disease and autoimmunity: general prac- tice-based epidemiological research [J]. Prim Care Respir J, 2014,23 ( 1 ) : 14-21.
  • 2Shah A. The pathologic and clinical intersection of atopic and autoimmune disease [J]. Curt Allergy Asthma Rep, 2012, 12 (6) :520-529.
  • 3Sheikh A, Smeeth L, Hubbard R. There is no evidence of an in- verse relationship between TH2-mediated atopy and TH 1-medi- ated autoimmune disorders." lack of support for the hygiene hy- pothesis [ J ]. J Allergy Clin Immunol, 2003,111 ( 1 ) : 131 - 135.
  • 4Robinson KM, Manni ML, Biswas PS, et al. Clinical conse- quences of targeting IL-17 and TH17 in autoimmune and aller- gic disorders [J]. Curr Allergy Asthma Rep, 2013, 13 (6) : 587-595.
  • 5Raab A, Sengler C, Niewerth M, et al. Comorbidity profiles among adult patients with juvenile idiopathic arthritis : results of a biologic register [J]. Clin Exp Rheumatol, 2013, 31 (5) : 796-802.
  • 6Zhang WM, Xu LY, Lu YM, et al. Atopy in children with system- ic onset juvenile idiopathic arthritis(SoJIA) is associated with a worse outcome [J]. Immunopharmacol Immunotoxicol, 2014, 36 (2) : 176-181.
  • 7Fsadni P, Fsadni C, Fava S, et al. Correlation of worldwide inci- dence of type 1 diabetes (DiaMond) with prevalence of asthma and atopic eczema (ISAAC) [J]. Clin Respir J, 2012, 6 (1) : 18-25.
  • 8Liphaus BL, Jesus AA, Silva CA, et al. Increased IgE serum lev- els are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus [J]. Clinics, 2012, 67( 11 ) : 1275-1280.
  • 9郭茹茹(综述),曹兰芳(审校).特应质对儿童风湿病发病的免疫机制研究进展[J].国际儿科学杂志,2014,41(1):61-64. 被引量:3
  • 10Radman M, Golshiri A, Shamsizadeh A, et al. Toll-like recep- tor 4 plays significant roles during allergic rhinitis[J]. Allergol Immunopathol(Madr ) ,2014,s30(14) : 1-4.

二级参考文献107

  • 1邵洁,夏振炜,李云珠,俞善昌.IgE介导的食物过敏诊断程序及临床评价[J].临床儿科杂志,2007,25(1):23-25. 被引量:30
  • 2Wurtzen PA, Lund L, Lund G. Chemical modification of birth allergen extract leads to a reduction in allergenicity as well as immunogenicity [J]. Int Arch Allergy Immunol, 2007, 144 (4) : 287-295.
  • 3Leonardi S, Marchese G, Marseglia GL. Montelukast in allergic diseases beyond asthma [J ]. Allergy Asthma Proc, 2007,28 (3) : 287-291.
  • 4Spangfort MD, Larsen JN. Standardization of allergen-specific immunotherapy vaccines [J]. Immunol Allergy Clin North Am, 2006,26(2) : 191-206.
  • 5Gonzalez RR, Ibarrola I, Arilla MC. Genetically engineered hybrid proteins from parietaria judaica pollen for allergen-specific immunotherapy [J]. J Allergy Clin Immunol, 2007, 120 (3) : 602-609.
  • 6Popescu FD. Antisense and RNA interference-based therapeutic strategies in allergy [J]. J Cell Mol Med, 2005, 9 (4) : 840-853.
  • 7Lazarczyk M, Grzela K, Grzela T. Immunostimulatory oligonucleotides in therapy of allergic diseases [J]. Expert Opin Biol Ther, 2005,5 (4) : 525-536.
  • 8Francis JN, Larche M. Peptide-based vaccination: where do we stand? [J]. Curr Opin Allergy Clin Immunol, 2005, 5 (6) : 537-543.
  • 9Weiss R, Hammerl P, Hartl A. Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases [J]. Curr Drug Targets Inflamm Allergy, 2005,4(5 ) : 585-597.
  • 10Hartl A, Weiss R, Hochreiter R. DNA vaccines for allergy treatment [ J ]. Methods, 2004,32( 3 ) : 328-339.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部